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Abstract How are public perceptions towards synthetic
biology likely to evolve? Which factors will impact the
framing of this emerging technology, its beneﬁts and risks?
The objective of this article is not to draw exhaustive
conclusions about public perceptions of synthetic biology,
but rather to provide readers with a review of integrated
ﬁndings from the ﬁrst quantitative and qualitative research
ever conducted on this subject in the United States. Syn-
thetic biology survey research shows two clear ﬁndings.
The ﬁrst is that most people know little or nothing about
synthetic biology. Second, notwithstanding this lack of
knowledge, respondents are likely to venture some remark
about what they think synthetic biology is and the tradeoff
between potential beneﬁts and potential risks. Finding only
some support for the ‘‘familiarity argument’’—according to
which support for emerging technologies will likely
increase as awareness of them develops—this article sug-
gests that analogs to cloning, genetic engineering and stem
cell research appear to be recurrent in the framing process
of synthetic biology. The domain of application seems to
be another decisive factor in the framing of synthetic
biology. Finally, acceptance of the risk-beneﬁt tradeoff of
synthetic biology seems to depend on having an oversight
structure that would prove able to manage unknowns,
human and environmental concerns, and long-term effects.
The most important conclusion of this study is the need for
additional investigation of factors that will shape public
perceptions about synthetic biology, its potential beneﬁts,
and its potential risks.
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Introduction
Synthetic biology is a ﬁeld that promises advances in
energy, healthcare, and other areas. How much do Amer-
icans know about it? Do members of the public think
potential beneﬁts of this emerging technology will out-
weigh potential risks?
These questions were part of a representative national
telephone survey of 1,003 U.S. adults conducted by Peter
D. Hart Research Associates (hereafter, Hart survey) in
August 2008 on the behalf of the Project on Emerging
Nanotechnologies at the Woodrow Wilson International
Center for Scholars (Hart Research Associates 2008). The
poll marks the ﬁrst time Americans have been asked in a
phone survey about synthetic biology. A few months
before, in March 2008, the Cultural Cognition Project
(CCP) at Yale Law School conducted an on-line survey
study of 1,500 Americans (hereafter, CCP survey) aimed at
determining what members of the public think about
potential beneﬁts and potential risks of synthetic biology
(Kahan et al. 2009).
However, survey data of this kind seldom provide a
sufﬁciently detailed picture from which to adequately
interpret national trends. Survey research should be
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DOI 10.1007/s11693-009-9035-6complemented by qualitative contextual studies intended to
explore popular understandings and images of new tech-
nology as well as longitudinal media analysis designed to
reveal signiﬁcant patterns in press coverage.
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To this end, this contribution also uses the ﬁndings of
two focus group sessions conducted in Baltimore, Mary-
land, on August 6, 2008, among (18–65 year old) adults—
one among women and one among men—to contextualize
the results of the two above-mentioned quantitative surveys
and to explore more in depth both uninformed and
informed perceptions of synthetic biology in the United
States.
Both surveys focused on the questions of U.S. public
awareness of synthetic biology and perceptions of its risk-
beneﬁt tradeoff. The Hart survey also included a third
open-ended question on the words and images used by
members of the public to describe synthetic biology. This
constitutes a set of representative data that can be used to
gauge general appraisal of synthetic biology risks in the
United States. However, the two focus groups added
insights on what speciﬁc applications may be welcomed by
members of the public and which types of perceived risks
may lead to public uneasiness. The focus groups also
provided data about the framing of synthetic biology that
would be least accessible without the kind of interaction
found in a group setting—listening to others’ verbalized
experiences stimulates ideas and experiences in partici-
pants. Finally, the focus groups also gave an appraisal of
U.S. public conﬁdence in different institutions/communi-
ties to regulate and tell the truth about synthetic biology.
The objective of this article is not to draw exhaustive
conclusions about public perceptions of synthetic biology,
but rather to provide readers with an integrated review of
ﬁndings from the ﬁrst quantitative and qualitative research
ever conducted on this subject in the United States. How-
ever, while two reports
2 have already been published on the
previously mentioned quantitative data, no article has yet
reported on the qualitative data and this is why, in this
context, the present article gives qualitative insight into
what words, images, and cognitive shortcuts to previous
technologies members of the public use to frame synthetic
biology, what applications they potentially welcome, what
kind of perceived risks would prove acceptable to them,
and what actors and parameters would increase their trust
in society’s ability to manage synthetic biology’s techno-
logical risks.
Materials and methods
Quantitative studies
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From August 20 to 25, 2008, Peter D. Hart Research
Associates conducted a nationwide survey among 1,003
adults about awareness of and attitudes towards synthetic
biology. At a 95% conﬁdence level, the data’s margin of
error is ±3.1 percentage points.
The CCP survey was based on a sample consisting of
1,500 U.S. adults recruited to be members of a nationally
representative online panel by Polimetrix, a ﬁrm that spe-
cializes in academic and commercial public opinion
research. The study was conducted using Polimetrix’s
online facilities: cf. http://www.polimetrix.com/documents/
YGPolimetrixSampleMatching.pdf).
Qualitative study
The Project on Emerging Nanotechnologies at the Wood-
row Wilson International Center for Scholars and Peter
D. Hart Research Associates conducted two focus groups
in Baltimore, Maryland on August 6, 2008, with
(18–65 year old) adults—one made up of women (11) and
one made up of men (9)—to explore both uninformed and
informed impressions of synthetic biology. These two
focus groups were part of a continuing effort by the Project
to analyze public perceptions of emerging technologies and
public attitudes toward the governance of these technolo-
gies and their societal implications. The results of these
focus groups are limited and should not be considered to
represent anything more than a sample of public opinion
toward synthetic biology and should not be used to draw
deﬁnitive conclusions. Detailed information on the focus
groups, i.e. experimental conditions and participants’
background, is provided in supplementary materials.
Results
Public awareness of synthetic biology and initial
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perception of risk-beneﬁt tradeoff
Most Americans remain unfamiliar with synthetic biology.
Some 82% of respondents to the online CCP survey
reported knowing ‘‘nothing at all’’ or ‘‘just a little’’ about
1 The following report (Pauwels and Ifrim 2008) is devoted to
analyzing synthetic biology press coverage in the United States and
Europe during 2003–2008. When the results of this media analysis
conﬁrm or contradict some of the present U.S. public perception data,
it has been mentioned in the footnotes.
2 Cf. Hart Research Associates (2008), Kahan et al. (2009).
3 Further information on the methods and materials used in both
quantitative surveys has been extensively developed in the two
following reports: Kahan et al. (2009), Hart Research Associates
(2008).
4 In the present article, the term ‘‘initial’’ refers to the assessment of
the participants’ awareness of synthetic biology before any introduc-
tion to the science.
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123synthetic biology while only 16% reported knowing a
‘‘moderate amount’’ and only 2% reported knowing ‘‘a lot’’
(Kahan et al. 2008b, 2009). The nationwide phone survey
conducted by Peter D. Hart Research Associates indicates
similar ﬁgures: just 9% of Americans said that they have
heard a lot or some about synthetic biology, including a
mere 2% who indicate they have heard a lot about it;
another 22% of adults said they have heard just a little
about this area of science, and a full 67% have heard
nothing at all about it (Hart Research Associates 2008).
The small proportion of Americans who express any
awareness of synthetic biology are most likely to say that
they have heard about it on television, from the news
media, or in a newspaper.
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Both the CCP and the Hart surveys show two clear
ﬁndings. The ﬁrst is that most people know little or nothing
about synthetic biology. Second, notwithstanding this lack
of knowledge, people are likely to express an initial
opinion about synthetic biology, its potential beneﬁts, and
its potential risks. According to the Hart survey, 7 in 10
Americans offer some remark about what they think syn-
thetic biology is or what images, words and phrases it
conjures in their minds despite their low level of awareness
of the technology (Hart Research Associates 2008). Even
with this low level of awareness, a two-thirds majority of
adults (66%) is willing to express an initial opinion
regarding the tradeoff between potential beneﬁts and
potential risks of synthetic biology. They are slightly more
likely to think that the beneﬁts will outweigh the risks
(21%) than the risks will outweigh the beneﬁts (16%),
while 29% believe that the risks and beneﬁts will be equal.
These last ﬁndings are conﬁrmed by the CCP survey in
which, despite a similar degree of unfamiliarity, most
subjects ventured an opinion one way or the other on the
potential beneﬁts and potential risks of synthetic biology
(Kahan et al. 2008b, 2009). Again, they are more likely to
agree that the beneﬁts of synthetic biology will outweigh
its risks (54%), while 43% disagree with this proposition.
The discussions among the focus groups’ participants
conformed to this general pattern. Only 6 among the 20
total participants in the focus groups (30%) said that they
knew what synthetic biology was prior to receiving any
background readings. These results indicate the relatively
limited level of awareness of the ﬁeld among the partici-
pants and corroborate the results of the quantitative studies.
However, even with limited awareness of synthetic biol-
ogy, a solid majority of the focus groups’ participants were
willing to give a brief description of what they think
synthetic biology is and elaborate on its potential before
receiving any information about the technology.
Informed
6 perception of the risk-beneﬁt tradeoff
of synthetic biology
The CCP survey suggests that how familiar respondents
reported being with synthetic biology was not strongly
associated with their perceptions of its risks and beneﬁts
(Kahan et al. 2008b, 2009). Fifty-six percent of the
respondents who were ‘‘relatively familiar’’ with synthetic
biology (that is, those who professed to know a ‘‘moderate
amount’’ or ‘‘a lot’’) agreed that its beneﬁts would out-
weigh its risks along with 54% of those who were ‘‘rela-
tively unfamiliar’’ (those who reported knowing either
‘‘a little’’ or ‘‘nothing at all’’ about it). Because the 56% of
those who professed being familiar with synthetic biology
mirrors the 54% of those who professed being relatively
unfamiliar, one might infer that the knowledge vanguard
includes both groups predisposed to see risks and groups
predisposed to see beneﬁts in this novel technology. This
ﬁnding is only modestly surprising. Previous studies have
illustrated that knowledge is a weak predictor of public
attitudes (Gaskell et al. 2004; Douglas and Wildavsky
1982; Bauer et al. 2007) and have given evidence for the
rejection of the familiarity hypothesis—according to
which, support for emerging technologies increases as
awareness of them develops (Kahan et al. 2008a;
Macoubrie 2006).
Converging with the above-mentioned results of the
CCP survey, the Hart survey shows that, after learning
about synthetic biology and being informed of its potential
risks and beneﬁts, the greatest shift in public opinion is
toward risks (see Fig. 1). Upon hearing the information
about synthetic biology, 29% of adults say that the risks
and the beneﬁts are equal (no change from the same
question measuring non-informed perception), 28% believe
the beneﬁts outweigh the risks (a 7-point increase), and
35% think the risks outweigh the beneﬁts (a 19-point
increase).
As an illustration of these quantitative ﬁndings, a com-
parison of the uninformed and informed perceptions of the
focus groups’ participants reveals that how much partici-
pants knew about synthetic biology had little relation to
their framing of its risks and beneﬁts. In fact, confronting
the focus group participants with balanced information
about synthetic biology did not simply lead to more or less
support for the technology but to a more nuanced level of
5 Pauwels and Ifrim (2008, p. 17) indicates that the number of news
stories that mention the potential beneﬁts of the technology outnum-
bered those mentioning potential risks, with more than 50% of
American news stories exclusively mentioning the potential beneﬁts.
6 In the present article, the term ‘‘informed’’ refers to opinions
expressed after participants were asked to read a brief description of
synthetic biology that consisted of a one-sentence deﬁnition and a
paragraph explaining the basic facts of the science.
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123discussion which inter alia shows the participants’ relative
ambivalence toward ‘‘creation of life’’ or ‘‘playing God’’
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aspects of the technology. The qualitative approach adop-
ted here yields additional insights into how lay people
frame synthetic biology and its implications.
Framing synthetic biology
The Hart survey provides us with representative answers to
the following single open-ended question: ‘‘Regardless of
how much you have heard about synthetic biology, what do
you think synthetic biology is? What ideas, images, words,
or phrases do you associate with synthetic biology?’’
Nearly 3 in 10 (29%) adults say: ‘‘I do not know’’ or
‘‘nothing’’. Nearly 3 in 10 (29%) adults declare that syn-
thetic biology is something man-made, artiﬁcial, fake,
unnatural, or not real. One in 10 (11%) says that it has to do
with cloning, genetic engineering, or genetic manipulation;
another 7% say it has to do with altering biology or bio-
logical make-up; and 4% explain it as creating artiﬁcial life
(Hart Research Associates 2008). The inclusion in the Hart
survey of this open-ended question gives us a unique
opportunity to compare the Hart ﬁnding to the discussions
engaged by the participants in the focus groups about the
framing of synthetic biology.
The discussions among the focus groups participants
illustrate the ﬁndings of the Hart survey, according to
which the most common reply to the question of what is
synthetic biology is a variation on the theme that synthetic
biology is ‘‘man-made,’’ ‘‘artiﬁcial,’’ or ‘‘not natural’’.
Initial descriptors used by the focus groups’ participants
When trying to describe synthetic biology in their own
words, participants relied heavily on adjectives and images
(or products) that might be associated with synthetic biol-
ogy. The images and words that, for the participants,
epitomized the development of synthetic biology, were
borrowed from medical or industrial activities—products
such as medicines, vaccines, and plastics. It is worth noting
that the adjective ‘‘man-made’’ was cited more than ﬁve
times in each focus group during the description process.
Other recurrent adjectives were ‘‘artiﬁcial,’’ ‘‘created,’’
‘‘unnatural,’’ and ‘‘synthetic.’’ When elaborating on the
purpose of the technology, they made extensive use of the
verbs ‘‘altering’’ and ‘‘duplicating,’’ while the expression
‘‘improving the quality of life’’ was also introduced several
times.
Impressions and descriptions of synthetic biology were
explored and discussed in depth in the focus groups. These
discussions led to brief deﬁnitions (see Fig. 2) being given
by the focus groups’ participants which, to some extent,
mirror the emphasis on the ‘‘man-made’’ aspects
(‘‘replacement’’ by artiﬁcial objects or robots) of synthetic
biology as mentioned in responses in the Hart survey.
Initial analogs used by the focus groups’ participants
Participants also tended to describe synthetic biology by
drawing parallels with other biotechnology or biomedical
ﬁelds. These analogs (Table 1) show how participants
framed the concept of synthetic biology and what other
technologies they associated with it. And it is why these
analogs or references might be crucial to anticipating the
lines along which future public debates about synthetic
biology may evolve.
Before being given a deﬁnition of synthetic biology and
being informed of potential applications for the technology,
participants tended to view the ﬁeld in relation to previous
technologies such as cloning, stem cell research, and
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Fig. 1 Initial and informed perceptions of the synthetic biology risk-
beneﬁt tradeoff (n = 1003, Hart Research Associates 2008)
7 What experts call the ‘‘playing God’’ argument is well explained in
the following excerpt of Scheufele et al. (2008, p. 1): ‘‘Recent
research also suggests that religious beliefs may be part of the value
system people use when they make sense of science and technology
more broadly. This may be due to perceptions that there are normative
inconsistencies between science and religious beliefs, illustrated by
the view that science interferes with nature—or is equivalent to
playing God—and is therefore incompatible with strong religious
beliefs. For instance, researchers have found that moral issues and
concerns about ‘‘unnatural’’ technologies were important in explain-
ing negative attitudes towards genetically modiﬁed (GM) organisms,
which were seen as disturbing nature and natural processes, and
perceived as risky and immoral. The potential conﬂict between
religiosity and science has been much more salient for nanotechnol-
ogy, in particular with respect to nano-bio-info (NBIC) technologies
that may, in the future, enable us to create life and intelligence (our
emphasis) at the nanoscale without divine intervention.’’
40 E. Pauwels
123genetic engineering. In Focus Group 1, when attempting to
describe synthetic biology, one of the female participants
mentioned the activity of ‘‘cloning, trying to change nat-
urally occurring living objects into man-made objects’’
(emphasis added). While professing his lack of knowledge,
one male participant in Focus Group 2 was capable of
making more accurate references to existing technologies:
‘‘I am not really sure. Genetic Engineering and cloning
come to my mind. Maybe something to do with recom-
bining DNA and technology’’ (emphasis added). When the
focus groups’ moderator asked participants to elaborate on
these initial analogs to provide a brief deﬁnition of syn-
thetic biology, similar references came up in the discus-
sion. In Focus Group 2, one of the male participants
deﬁned synthetic biology as ‘‘continuing to utilize cloning
procedures to ‘grow’ human organs from stem cells, to
perhaps genetically engineering whole organisms’’
(emphasis added).
References made to existing technologies are a window
into participants’ initial perceptions of synthetic biology.
These analogs provide a way of looking ahead by looking
back. They contribute to the framing of the technology by
the participants and reveal the cognitive shortcuts that they
will likely use when learning more about synthetic biology.
The next section compares preliminary analogies used
by the participants with their comments and reactions after
being given information about synthetic biology. This
comparison allows us to evaluate the inﬂuence of new
information on the attitudes and perceptions of the partic-
ipants towards synthetic biology and to assess the extent to
which they will rely on their previously conceived cogni-
tive references or shortcuts to process the information.
Analogs used to express reactions to synthetic biology
readings
Analogs associated with synthetic biology were generally
similar before and after participants had read an explana-
tory paragraph about synthetic biology. References to
cloning, stem cell research, and genetic engineering were
the most popularly used analogs to express reactions to
synthetic biology readings in both focus groups and were
used to make positive and negative points about synthetic
biology. For example, one of the female participants ref-
erenced cloning when speaking about the ﬁeld’s potential
medical applications: ‘‘It makes me feel, I was saying that
it makes me think of cloning and all that, the engineering,
and it gives me great possibilities as far as maybe detecting
genetic, you know, disorders and whatever and trying to
ﬁnd some cures or ways of doing something to like an
embryo, whatever, to get rid of the problems.’’ Another
female participant criticized the instrumental aspect of the
potential use of genetic engineering: ‘‘It sounds like it’s a
boutique little shop area, and you sit out there wherever
you want, and everything is tailored to what you need and
what you desire. But, you know, kind of going back to if
we start genetically altering kids or whatever in the future,
it may not necessarily lead to the result that we would have
expected.’’
While focusing at ﬁrst on the science-ﬁction scenarios
linked to the use of cloning and genetic engineering—
references were made to Jurassic Park and Gattaca—the
debate among the male participants succeeded in distinguishing
“Creating man-made items to replace naturally occurring living objects or cells.”  
–Female Participant 
“Anything that’s man made, science and the like, stuff like replacing what we call natural with 
the artificial.”
–Male Participant 
“It sounds like a man-made replacement for existing biological organisms or products, like 
everything from it almost seems artificial, flavoring up to artificial tissue for the body.”  
–Male Participant  
“Robots.”                                                                                                            
  –Female Participant 
“Cloning and stem cells and harvesting organs for the future.”  
–Male Participant 
Fig. 2 Some brief deﬁnitions of
synthetic biology given by the
focus groups’ participants
Table 1 Analogs used in focus group discussions of synthetic
biology
Focus Group 1 (female
participants, n female = 11)
Focus Group 2 (male
participants, n male = 9)
Cloning Cloning, cloning procedures
Genetic engineering Genetic engineering
Stem cell research Stem cell research
Recombinant DNA research
Regenerative medicine
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123cloning processes from the synthetic biology approach:
‘‘But this seems like you just clone. But, well, we’re not
cloning. We’re just creating our own DNA.’’
Also notable were the general references to stem cell
research that appeared in both focus groups. However,
among the male participants, the point was made that, in
the case of stem cell research, the United States had failed
to fully develop the research potential, especially in com-
parison with other countries: ‘‘Look at the problem they
have with cloning, because they were worried they were
going to clone a man. Then you go over to the other side,
the religious side, and you’re dealing, I’m not getting into
that, obviously, but you’re dealing with all that. So, I mean,
like with the stem cells…because of this…but yet they
could have saved a lot of people.’’ This reasoning led this
particular participant to reconsider the ‘‘playing God’’
analog used several times in the focus groups’ discussions
to characterize the ramiﬁcations of synthetic biology:
So I believe if they try this, you’re going to have
religious people coming out, saying that you’re
playing God, and you can’t do this. And other people
will come out and say, well, God put this knowledge
into man. Therefore, if he didn’t want it done, it
wouldn’t have happened, to get to the other side of it.
It’s like a bottomless pit here. I’ve had discussions of
this with people, and you can’t argue with them.
Speciﬁc comments to express reactions to synthetic biology
readings
8
In reaction to the reading materials on synthetic biology,
participants expressed relative ambivalence about the
‘‘engineering’’ nature of synthetic biology and the goal of
re-designing life forms. One of the male participants
expressed this ambivalence in the following terms: ‘‘The
prospect excites me; I think it has to do with attempting to
create something from nothing, or from very little. I feel it
could be beneﬁcial to us. It could also be dangerous if we
do not research it enough to ﬁnd out any long-term
effects.’’
Other comments revealed discomfort with the term
‘‘synthetic biology’’ and fears about the technology being
usedinanegativeway:‘‘Thisterm[syntheticbiology]makes
me feel scared. This could lead to huge scientiﬁc advances,
butitcanalsoleadtocountriesorpeopleusingitfortheirown
‘evil agendas.’ It reminds me of Jurassic Park.’’
Another area of uneasiness for the participants was the
idea of synthetic biology being used in ‘‘creating life.’’ One
of the female participants expressed her apprehension by
highlighting her uncertainties about researchers being able
to control or manage such experiments: ‘‘I feel concerned
because, not being perfect, we believe we know what is best
in creating life. As in science-ﬁction movies, when we do—
in time—it goes in a direction we didn’t think about…I
believe when life is created it is meant to be created that
way for a purpose we may not even know right now.’’
The discussion about the possibility of creating new
genetic code and its subsequent instrumental use seemed to
provoke a general feeling of discomfort among the par-
ticipants: ‘‘This ‘synthetic biology’ involves engineering of
genetic codes, requisites to genetic engineering. I mean, it
seems like, to me, that with this, you don’t even need a
base DNA. You just create it.[ …] I don’t like it’’; ‘‘Making
a brand new code, I think it is dangerous.’’
Although feeling positive about the ﬁeld’s possible
applications, one of the male participants expressed his
moderate concern about the limits of synthetic biology: ‘‘It
may be highly proﬁtable. Maybe it could be used to extend
life. It seems exciting, but makes me somewhat uncom-
fortable. Where are the limits?’’ This intuitive feeling of
discomfort led one of the male participants to question the
limits of human agency with the well-known ‘‘playing
God’’ argument: ‘‘It sounds like we are playing God. Who
are we as humans to think we can design or redesign life? It
might be nice to be able to do so, but is it right? It seems
there are many ethical and moral issues. Perhaps we are
getting too arrogant.’’ The expression ‘‘playing God’’ was
used by three different participants in focus Group 2.
Potential applications matter
Another relevant element in the framing process of
emerging technologies—and this appears to be the case in
the focus groups on synthetic biology—is that applications
matter. Potential applications of the technology in question
continue to frame public perception.
In the third phase of the focus groups, participants were
provided with several speciﬁc examples of how synthetic
biology is either currently being used or is being devel-
oped. Among these speciﬁc examples, participants were
invited to circle what application they considered most
promising. Synthetic biology, of course, spans a very wide
range of potential applications from health to energy and
8 American press analysis identiﬁed a heavy focus on engineering
metaphors and inter alia the term ‘‘designer organisms’’ to describe
synthetic biology. American press analysis show that metaphors
illustrating the ‘‘playing God’’ or ‘‘creation of life’’ aspects of the
technology were employed, as well, but usually in reports emphasiz-
ing its potential risks (Pauwels and Ifrim 2008, p. 12). Some of the
headlines of the American newspapers speak for themselves: ‘‘As
DNA research advances, science plays God ever more; New life
forms—The line between biological and artiﬁcial is about to blur as
life is synthesized in labs with man-made genetic material’’ (The
Seattle Times, December 24, 2007); ‘‘Scientists enter brave new world
of synthetic life’’ (The Houston Chronicle, December 17, 2007);
‘‘Synthetic DNA on the brink of yielding new life forms’’ (The
Washington Post, December 17, 2007).
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123environment, and the examples we provided to the partic-
ipants reﬂected this diversity. As might be expected, the
type of synthetic biology application inﬂuences the form of
the discussion, anticipated reservations, and conclusions.
Table 2 presents the rankings of potential applications of
synthetic biology according to participants’ priorities. As
shown by this ranking, both medical and energy prospects
were equally promising to the focus groups’ participants
when invited to select applications.
9 However, interest-
ingly, when it came to more in-depth discussions of the
technology’s prospects, participants in both focus groups
were far more easily engaged in positive debates about
energy than health applications.
In both focus groups, the top-ranked application of
synthetic biology was creating new, cheaper, and cleaner
sources of energy. Four participants in each focus group
chose ‘‘biofuels’’ as the most promising application. In
Focus Group 1, one female participant expressed her
enthusiasm by saying: ‘‘Sounds great, good deal, biofuels,
I love that.’’ Comments from male participants echoed this
enthusiasm: ‘‘I really like the idea of generating, con-
structing a bacteria to generate hydrogen.’’ Within the
energy issue, participants also expressed their concerns
about protecting the environment. One of the female par-
ticipants said: ‘‘I like, about the biofuels, how they said it
produces cleaner fuels…That could be good as far as going
greener for the environment.’’ There was similar concern
among male participants: ‘‘That [bacteria generating bio-
fuels] would be fantastic, between that and, you know,
I believe we have already come up with some bacteria that
will eat away stuff in landﬁlls and pollutants and so forth
for environmental cleanup. Between those two, I think it
would be really helpful to the world.’’
Participants were more ambivalent about the beneﬁts of
medical applications being developed using synthetic
biology in the sense that their expectations (e.g. eradicate
genetic diseases or cure cancer) were as high as their
reluctance to use ‘‘engineered’’ or ‘‘re-designed’’ organisms
in their body. The predominant fear for several participants
dealt with possible negative health effects of synthetic
biology products used inside the body. One of the female
participants stated: ‘‘My concern, again, would be injecting
anything synthetic inside of my body. That’s just where it
causes concern for me because I understand they want to do
the research for it, but, I mean, I wouldn’t want to volunteer,
do it on me or my family, so that’s what concerns me.’’
Discomfort with the use of synthetic biology products in the
human body was also expressed by male participants,
among them: ‘‘Biofuels sound promising, but, you know,
some of the other stuff, about injecting into the body, in the
site of a cancer to attack the tumor. Anybody see…I don’t
know… what could happen with something like that?’’
Discussing synthetic biology medical and environmental
applications more in-depth, participants expressed dis-
tinctly negative reactions to the terms ‘‘synthetic’’ and
‘‘construct.’’ As explained by one of the female partici-
pants: ‘‘I crossed out the word ‘construct.’ It just kind of
bothers me when you’re thinking about, you know, espe-
cially things that you’re putting into your body. The word
‘construct’ just doesn’t sound natural, and it doesn’t sound
like what’s supposed to be going on.’’ The following quote
of a male participant gives better insight into why the word
‘‘construct’’ epitomizes some of his concerns related to
biosafety: ‘‘So, you know, if you modify a bacteria, I’m not
a scientist, so if you modify something, at least it’s already
been here, so it still hopefully maintains some of its ori-
ginal properties. But talking about constructing something
that has never existed in environment before and then
releasing it into the environment, to me, that’s dangerous
because in all reality, you really have no idea what’s going
to happen once it gets into the environment.’’
As the discussion about the potential applications of
synthetic biology included, in both focus groups, some of
the participants’ concerns, the next section analyzes more
in-depth the perceived risks of synthetic biology.
Perceived risks of synthetic biology
This section deals with the question of how the focus
group participants framed perceived risks of synthetic
biology. In general, these perceived risks were linked to
Table 2 Overall rankings of
potential applications of
synthetic biology
a
a Percentages reﬂect the
number of participants in each
group who valued the given
application the most
Potential applications
of synthetic biology
Focus Group 1 (female
participants, n female = 11) (%)
Focus Group 2 (male
participants, n male = 9) (%)
Biofuels 36 44
Drugs for treating diseases 9 33
New ways to treat cancer 27 11
Sensing harmful contaminants 0 0
Cleaning up the environment 27 11
9 As indicated by the American press analysis (Pauwels and Ifrim
2008, p. 18), potential energy beneﬁts draw almost as much attention
as health beneﬁts in news stories about synthetic biology.
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ronmental concerns, and long-term effects. ‘‘Unknowns’’
and ‘‘long-term effects’’ apply to concerns for which
outcomes and effects cannot be predicted by anyone,
including experts in synthetic biology. This category
includes concerns such as ‘‘unknown risks and conse-
quences,’’ ‘‘unintended uses,’’ ‘‘how our manipulation will
effect natural laws,’’ and ‘‘unpredictability if synthetic
biology follows its own natural laws.’’ Only a few par-
ticipants’ comments were illustrating what experts call
biosecurity concerns.
10
The main concern raised by the participants and dis-
cussed at length regarded possible effects of synthetic
biology on the environment. In most cases these concerns
took the form of questions like: ‘‘What happens to syn-
thetic microbes after their useful life is over?’’ and ‘‘What
effect would they have in the environment?’’ One male
participant, for example, vocalized concerns with the
development of biological systems to target environmental
pollution: ‘‘Well, for instance, the example of that if they
create a bacteria that’s going to eat the oil slick, and we
know after throwing the bacteria on the water, it’s going to
die after so many hours in the temperature of the water
that’s there, if we know that’s going to happen without a
doubt, then I would be okay with it. But if we don’t
know…’’ This biosafety concern was echoed by several
female participants. One of them said: ‘‘My concerns were
the harming of the environment and the unexpected results
and side effects. This is kind of scary.’’
The discussion rapidly led to a related issue—the long-
term effects of synthetic biology research and unknowns.
After learning what experts in the ﬁeld of synthetic biology
have identiﬁed as potential risks associated with develop-
ment of the technology, one of the female participants
expressed her reluctance: ‘‘They identify a lot of risks, but
then they also use words that, things like might, poten-
tially…there are questions. So there’s all the advancement.
They don’t know what the side effects are going to be, and
they may not be able to research it until these things have
been around for 20–30 years. And at that point, it may be
too late. So I think there’s too many might’s and too many
possibly’s for me to feel totally comfortable.’’ A similar
concern was expressed by a male participant: ‘‘You can put
something out, and it looks great, and then you ﬁnd 2 years
down the road that, it’s an organism, and it starts to mutate,
and now they can’t control it, and now you run into this
other problem. It’s almost … because if it gets totally out
of hand like nuclear proliferation…’’ Some participants
were more assertive, like this man who exclaimed:
‘‘They’re dealing with chaos. They’re dealing with the
unknown.’’
Linked to the issue of the unknown impact on health and
the environment was the issue of ‘‘who is in charge?’’—the
idea that the level of security of technological development
intrinsically depends on ‘‘whose hands it is in and what
they intend to do with it, the potential being limitless,
depending on intentions.’’ Usually this concern takes the
form of questions like: ‘‘And I think the biggest concern
would be who would be controlling the people that are
doing this?’’ and ‘‘Who or what factor should be the motor
and implementer of these inventions?’’ One of the male
participants was particularly afraid of the technology being
used for evil purposes—what can be associated with bio-
security concerns. His argument was very simple—other
countries are probably working on synthetic biology, and
those whose purposes are less than pure, whether foreign or
domestic, could easily obtain the technology. Here is his
comment: ‘‘Who has the knowledge and information? How
far would they go with it? I mean, even though we have, in
this country, we have laws about scientists efforts, but,
I mean, what’s to stop a scientist who says, well, I’ll make
this bacteria and this organism and, well, I can’t do it in the
United-States, so let me go over to some Third World
country where they don’t give damn.’’
Finally, both groups expressed a concern that we should
not be ‘‘messing with’’ God’s creation, natural selection, or
what is human. The argument was often expressed in
simple terms: ‘‘I mean, you know, again, when man has
tried to play God, it’s always been disaster, you know,
because this is, we don’t foresee that take place in nature.’’
One of the female participants was able to elaborate,
raising questions about the ethics of creating life: ‘‘I just
want to say that I think the overall goal is good, the quality
of life and making things cheaper and easier, and I guess,
for me, the biggest concern is the ethics. You know, who
would determine, the last bullet here was talking about life,
and it makes me think who determines if this is life or… if
we move forward with this, then who sets the boundaries
within whatever it is that they are doing? And then who
would protect whatever a project would be?’’ This is ech-
oed by another female participant: ‘‘I was going to add the
exact same thing, the moral and ethical boundaries are
just—who is going to set them?’’
Recurring concerns with letting synthetic biology
research develop solely within the context of self-regula-
tion by the scientiﬁc community led to the examination of
what participants’ attitudes were regarding the best
approach to managing the risks associated with synthetic
biology.
10 At this stage, it may interesting to notice that, when it comes to
potential risks associated with synthetic biology, the American press
was primarily focused on biosecurity risks, with ethical concerns
coming in second and receiving approximately half as many mentions
as biosecurity (Pauwels and Ifrim 2008, p. 19).
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synthetic biology
In the ﬁnal phase of the focus groups, participants’ attitudes
towards federal regulatory agencies and other potential
actors in the regulation of synthetic biology were explored.
Best approach to managing the risks associated with
synthetic biology
Participants were invited to discuss some different poten-
tial approaches to how society might try to manage the
risks associated with synthetic biology. The results are
reﬂected in Table 3.
Although both groups were skeptical of the ability of the
federal agencies to regulate the ﬁeld, oversight by the gov-
ernment was mostoften chosen asthe best way ofregulating
synthetic biology. Here is a comment from a male partici-
pant: ‘‘I feel [federal government] it’s the best approach
because I don’t agree with banning it [the technology].
Technology should advance, and in order to advance, you
have, there’s risks with it. Just anything that we have today
comes at a risk. But I don’t trust, you know, I think of the
four, that the federal government would be the best. And I
guessitwouldbemoreinthespotlightthanjustsomeprivate
companyanditsinvestors.’’Hecontinuedhisexplanationby
referring to the broad principle of political accountability:
‘‘At least the government, technically, we choose the gov-
ernment, so if they screw up, we can vote them out of ofﬁce.
And with all of the people on television discussing every-
thing, it’s probably harder for the government to white wash
an issue as opposed to a private company.’’
Propositions for increasing public trust
After having discussed with the participants the best
approach to managing the risks associated with synthetic
biology, the focus groups’ moderator asked questions
concerning ways the federal government could work to
increase public trust. The concern over the competence of
regulatory agencies to handle synthetic biology brought out
many suggestions that scientists and/or research institutions
needed to participate in oversight along with the regulatory
agencies. One of the female participants expressed her
reason for involving scientists in the regulatory process:
‘‘I think they should be part of the team because they bring
so much knowledge and understanding.’’ The reasons for
this suggestion were as much about keeping the regulation
of synthetic biology above the political fray as it was about
involving experts in the regulatory process.
Participants also spoke about enacting a ‘‘hybrid’’
approach, a kind of private-public partnership that would
lead to a better system of ‘‘checks and balances.’’ As men-
tioned by one of the female participants: ‘‘I guess I would
feel more comfortable if there was a system of checks and
balances … like the government, not that that’s my ﬁrst
choice, but it seems like it’s the only independent option for
checking,asystemofchecksandbalances.’’Oneofthemale
participants went even further: ‘‘So, we’re going to have to
set up, I believe, a total new framework of so-called com-
missions and oversights.’’ Another male participant men-
tioned the idea of having a third-party overseeing the
industry activity: ‘‘… regulation by having a third party, an
unrelated organization, watch over the industry. And that’s
why we have them, because they have no interest. They are
notconnected.Theyarenotgettinganyproﬁt.Theyarethere
tocertifyor check,independentof those whoare making the
money.’’ This idea of a system of checks and balances
seemed to be, for one of the male participants, the best way
of securing accountability and providing the public with
information about the research applications: ‘‘The knowl-
edge that should something go wrong, there will be reper-
cussions,thechecksandbalancesthing,justsolongasifyou
know anything goes wrong, someone will be held account-
able. They won’t be just buying their way out of it. There
will be a nice little way to know.’’
Discussion
The present article is only the starting point in the critical
task of understanding how public attitudes toward synthetic
Table 3 Best approach to managing the risks associated with synthetic biology
a
Best approach to manage the risks associated
with synthetic biology
Focus Group 1 (female
participants, n female = 11) (%)
Focus Group 2 (male
participants, n male = 9) (%)
Require the federal government to regulate synthetic biology 36 44
Allow the scientiﬁc community and others involved
in advancements to regulate synthetic biology
55 0
Ban the further development and use of synthetic biology 9 44
Allow companies and private funders investing in R&D
to regulate synthetic biology
01 1
a Percentages reﬂect the number of participants in each group in favor of described approach
U.S. public perceptions of synthetic biology 45
123biology are emerging and how they will further evolve in
the coming decades. A number of issues remaining to be
investigated follow for those interested in analyzing public
perceptions of cutting-edge biotechnologies:
• Finding only some support for the ‘‘familiarity argu-
ment’’—according to which support for emerging
technologies will likely increase as awareness of them
develops—this article suggests that analogs to cloning,
genetic engineering and stem cell research appear to be
recurrent in the framing process of synthetic biology.
The domain of application seems to be another decisive
factor in the framing of synthetic biology.
• Within both focus groups’ discussions, a majority of
participants expressed reluctance regarding the ‘‘play-
ing God’’ or ‘‘creation of life’’ aspect of synthetic
biology. Unanswered by this analysis is the question of
the nature of the claims raised by this argument: does it
refer to polarization involving broad cultural/philo-
sophical dimensions or to polarization strictly linked to
religious values? The unease expressed during the
discussions by the focus groups’ participants about the
‘‘creation of life’’ aspect of synthetic biology do not
allow us to determine if this uneasiness is strictly linked
to religious concerns or embodies an array of philo-
sophical, religious, and cultural arguments. Indeed, the
‘‘creation of life’’ aspect was used in the focus groups’
discussions by both non-believers and participants
deﬁning themselves as coming from a religious back-
ground. The question of the inﬂuence of belonging to a
speciﬁc religion on the framing process of synthetic
biology and its implications should be tested further in
appropriate experimental studies across groups from
different geographic locations in the United States and
from different religious backgrounds.
• The acceptance of the risk-beneﬁt tradeoff of synthetic
biology seems to depend on having an oversight
structure that would prove able to manage unknowns,
human and environmental concerns, and long-term
effects.
The most important conclusion of this article is the need
for additional investigation of different factors that will
shape public perceptions about synthetic biology, its
potential beneﬁts, and its potential risks. Future analysis of
the framing process of emerging technologies will require a
range of interdisciplinary methods that are perceptive of
cultural values and the context of applications. This would
help scientists continue a winning strategy of listening to
public concerns on research—and responding appropri-
ately—so they can maintain the public trust, leading to
better co-evolution of science and society.
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